Pharmaceuticals
Goldman Sachs: Chinese Biotechnology Attracts Attention from Major Pharmaceutical Companies
Goldman Sachs reports that pharmaceutical companies are turning to Chinese biotechnology due to patent expirations.
Switzerland adopts most of the EU’s new Russia sanctions package
Switzerland has adopted most of the measures from the European Union’s latest sanctions package against Russia, according to Bloomberg. The move aligns Bern with the EU’s 20th sanctions package, which